Goldman Sachs’s Pediatrix Medical MD Stock Holding History

Goldman Sachs’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-28,000	Closed	-$1.31M	–	5495
2018 Q3	$1.31M	Hold	28,000	–	–	﹤0.01%	3885
2018 Q2	$1.21M	Sell	28,000 -47,000	-63%	-$2.25M	﹤0.01%	3954
2018 Q1	$4.17M	Sell	75,000 -10,500	-12%	-$576K	﹤0.01%	3044
2017 Q4	$4.57M	Buy	+85,500	New	+$4.03M	﹤0.01%	3080
2014 Q4	–	Sell	-50,200	Closed	-$2.75M	–	7229
2014 Q3	$2.75M	Buy	+50,200	New	+$2.85M	﹤0.01%	3612
2013 Q4	–	Sell	-76,400	Closed	-$3.83M	–	6743
2013 Q3	$3.83M	Sell	76,400 -2,400	-3%	-$117K	﹤0.01%	3222
2013 Q2	$3.61M	Buy	+78,800	New	+$3.53M	﹤0.01%	3074

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Goldman Sachs's MD Position: Q1 2026 in Review

Goldman Sachs increased its Pediatrix Medical (MD) stake by 8.2% in Q1 2026, buying an estimated $1.34M and bringing the position to 851,464 shares worth $18.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2521.

Goldman Sachs first reported a position in MD in Q2 2013 and has held it in 52 quarters since. The position peaked at $86M in Q4 2016. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.

Goldman Sachs held 851,464 shares of Pediatrix Medical worth $18.2M as of Q1 2026.
Goldman Sachs bought 64,195 Pediatrix Medical shares in Q1 2026, an estimated $1.34M.
Pediatrix Medical made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2521 holding.
Goldman Sachs first reported a position in Pediatrix Medical in Q2 2013 and has held it in 52 quarters since.
Goldman Sachs's Pediatrix Medical position peaked at $86M in Q4 2016.
296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.